Alternatives to WeGuide

OpenClinica is a leading provider of clinical data management software solutions. OpenClinica provides powerful tools to ensure that clinical trials are compliant and efficient. OpenClinica Enterprise, OpenClinica Participate and OpenClinica Randomize are the core products. OpenClinica is a powerful clinical trial platform that offers a wide range of tools for data collection, patient engagement, and study management. From electronic data capture (EDC) and eConsent to patient recruitment and real-time reporting, OpenClinica’s solutions automate and simplify the clinical trial process. With features like EHR-to-EDC integration and advanced reporting dashboards, the platform improves data accuracy, reduces delays, and enhances compliance. OpenClinica has been used in over 15,000 clinical studies, providing support for organizations around the globe, including government agencies and pharmaceutical companies, to conduct trials with confidence.

Castor offers an intuitive and comprehensive platform for managing clinical trial data, focusing on electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). The platform is optimized for decentralized trials, providing seamless tools for remote patient engagement and data collection. With real-time reporting, Castor helps researchers track trial progress and make data-driven decisions. The solution ensures compliance with industry regulations such as HIPAA, GDPR, and 21 CFR Part 11, making it ideal for life sciences organizations looking to enhance trial efficiency while maintaining high data integrity.

Numerous organizations globally rely on IQVIA to accelerate the drug development process, guarantee the safety and quality of products, enhance commercial efficacy, deliver appropriate treatments to patients, and ultimately promote improved health outcomes by facilitating access to and delivery of healthcare. Transform your approach to clinical development by seamlessly integrating data, technology, and analytics to streamline your trials. The outcome? Quicker decision-making and minimized risks, enabling you to provide transformative therapies at a faster pace. With its expertise rooted in data, sophisticated analytics, and deep industry knowledge, IQVIA offers tailored capabilities to clients throughout the healthcare landscape. Stay informed by exploring the latest insights and updates from IQVIA's data scientists, healthcare professionals, researchers, and other industry experts on crucial topics that resonate with your interests. From emerging industry developments to practical applications of our capabilities, a wealth of information awaits you here. Engaging with this content also empowers you to stay ahead in a rapidly evolving healthcare environment.

H1 Universe is an innovative platform that leverages artificial intelligence to enhance the management of healthcare data, offering users access to the most extensive global database of healthcare providers (HCPs). By merging information from various sources, such as public, private, and proprietary databases, H1 Universe provides valuable insights that are crucial for clinical trials, medical affairs, and commercialization efforts. This powerful tool enables healthcare teams to pinpoint essential stakeholders, refine clinical research processes, and make informed decisions swiftly, ultimately boosting overall efficiency within the healthcare landscape. Furthermore, the platform not only aids in real-time decision-making but also fosters collaboration among healthcare professionals, paving the way for improved patient outcomes.

Signant Health operates as a worldwide leader in evidence generation, striving to transform the landscape of clinical trials by connecting with patients in their environments and rethinking the route to validation. Their extensive range of clinical technology solutions includes electronic Clinical Outcome Assessments (eCOA), Electronic Data Capture (EDC), electronic clinician evaluations, and a cohesive eClinical platform. Additionally, they offer patient engagement solutions featuring a user-friendly app, eConsent for informed consent processes, and telemedicine functionalities. Furthermore, Signant Health delivers clinical data and analytics services, which include COA data analysis as well as the aggregation and interpretation of data. With a rich history spanning over three decades, they have played an instrumental role in supporting numerous trials and have been pivotal in hundreds of drug approvals, establishing themselves as a reliable ally for sponsors and CROs eager to provide high-quality data for informed trial decisions and regulatory submissions. Their commitment to innovation continues to shape the future of clinical research.

5thPort serves as a comprehensive digital platform for patient education, engagement, and electronic consent, applicable in various settings including individual medical practices, hospitals, health systems, and clinical research environments. The platform employs high-quality multimedia resources and a teach-back method to effectively educate patients and their caregivers about their diagnoses, treatment plans, and the associated risks and benefits of proposed procedures. Once patients are adequately informed, the digital eConsent feature fosters a more meaningful dialogue with healthcare providers. By utilizing 5thPort, users can expect to achieve notable outcomes including: 1. Saving 15 to 20 minutes during consultations without any extra effort, 2. Improving the overall patient experience, 3. Alleviating patient anxiety on the day of their visit, 4. Encouraging patients to take an active role in discussions about their healthcare with providers, 5. Mitigating nurse burnout, leading to a more efficient and harmonious healthcare environment. In essence, 5thPort not only streamlines the consent process but also enhances the overall quality of care delivered to patients.

Clinion eCOA allows you to conduct decentralised clinical trials, with patients participating remotely. Clinion eCOA allows study participant to report their health from their home using their smartphone. This allows clinicians to monitor patients in real time. Clinion eCOA integrates seamlessly with Clinion EDC. Trial participants can input daily outcomes directly. This eliminates data duplication and transcription errors, and provides clinicians with a real time view of patient progress. Multilingual forms are supported by the eCOA app, which makes it easier for patients to engage and provides cleaner data. The eCOA app's decentralised nature allows for faster and wider patient recruitment.

Medable offers an innovative software solution designed for the research and execution of clinical trials via a decentralized platform. This technology is focused on actively engaging patients remotely to ensure the collection of the most accurate results. Additionally, patients can conveniently provide their consent for digital assessments from a distance, and the platform is tailored to comply with local languages and regulatory requirements. Optimize the decentralization of your protocol with our adaptable, modular digital and decentralized clinical trial (DCT) platform. Facilitate extensive remote screening on a global scale and achieve your enrollment goals more swiftly. Create any type of screening assessment to fit your needs. Enhance the clarity of consent documents with responsive designs suitable for web and mobile devices. Deliver remote eConsent experiences to patients that rival popular consumer digital interfaces. With the capability to adapt to local regulations and languages, we offer global flexibility that accommodates diverse needs. By engaging patients and alleviating the challenges associated with travel and time constraints of on-site visits, you can significantly enhance patient access and involvement in the study. Ultimately, this approach not only streamlines the clinical research process but also prioritizes patient convenience and participation.

Health Studio™ provides an innovative, all-encompassing AI platform that brings together patient care, clinical research, and remote monitoring into one cohesive system. By effectively linking wearables, medical instruments, and patient information, it offers immediate insights, optimizes workflows, and improves health outcomes, thus revolutionizing healthcare into a more interconnected and data-centric journey. This advancement not only benefits healthcare providers but also empowers patients through better access to their health information.

uMotif is an innovative platform for eCOA/ePRO and eConsent, aimed at enhancing both clinical and real-world research efforts. Created with input from patients, this platform offers unmatched engagement, significantly improving the speed, quality, and precision of data collection. Through the integration of uMotif's eCOA/ePRO system with real-time glucose monitoring, the platform achieved remarkable compliance rates during a comprehensive diabetes study across Europe. In another instance, an immunology trial benefited from the patient-focused eCOA/ePRO solution, enabling the sponsor to fulfill data requirements a full six months ahead of schedule. Additionally, in a CNS study mandated by the FDA, participants utilized their personal devices to provide submission-ready ePRO data, showcasing the platform's versatility. uMotif's commitment to a patient-first design philosophy emphasizes a deep understanding of the patient experience and the factors influencing their behavior. This expertise not only ensures the development of software that addresses patient needs effectively but also results in extraordinarily high engagement levels for study sponsors, fostering a win-win environment for both parties.

Historically, clinical trials and medical research operated separately from the routine care provided in local healthcare facilities and by individual doctors. Many physicians remained unaware of ongoing research initiatives, leaving patients largely uninformed about studies that could enhance their treatment outcomes or health. Elligo has transformed this landscape by facilitating unprecedented participation in clinical research through access to a vast network of over 150 million patients and their comprehensive data, enabling doctors to present research opportunities to patients who might not otherwise encounter them. Traditional methods of recruiting participants often face challenges, such as the need for patients to travel to specific research sites, which can limit involvement. Moreover, studies indicate that patients are more inclined to participate in research when it is associated with their trusted healthcare provider, underscoring the importance of integrating clinical research into familiar medical environments. This approach not only bridges the gap between research and patient care but also empowers individuals to take part in potentially life-changing medical advancements.

DatStat’s cloud-based platform prioritizes the patient, whether in the context of care or the next significant clinical trial. This innovative platform enhances the ability of clinicians and researchers to engage, empower, and connect with patients like never before. Our solutions for clinical trials and healthcare are built on this patient engagement platform, which is utilized by some of the most forward-thinking healthcare organizations today. By collaborating closely with clients to grasp the unique requirements of their department, program, or initiative, the DatStat team customizes solutions within our web-based platform without the need for hard coding. In essence, we can expedite the launch of your project more efficiently than traditional custom coding or paper-based methods. By placing patients at the forefront, they can actively participate in the process, fostering better communication and enhancing your team's efficiency—all while contributing to improved outcomes for the patients themselves. As a result, our approach not only streamlines operations but also elevates the quality of care provided to patients.

The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.

Suvoda is a worldwide leader in clinical trial technology, focusing on intricate, life-preserving studies in fields like oncology, central nervous system conditions, and rare diseases. Established in 2013, the company provides a comprehensive platform featuring Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all aimed at streamlining essential patient interactions. Their innovative software design guarantees a fluid user experience, enabling accurate randomization, efficient drug supply management, and immediate data collection. With a strong commitment to improving patient understanding and alleviating the demands on trial sites, Suvoda's offerings are designed to evolve alongside the increasing complexities of clinical trials. Based near Philadelphia, with additional offices across Europe and Asia, Suvoda has successfully supported over 1,500 trials in more than 85 countries, showcasing their global reach and expertise in the field. Their dedication to innovation and excellence positions them as a vital partner in the advancement of clinical research.

Accelerate clinical innovation with an AI-enabled Clinical Research Platform designed to unify Early Phase CTMS, Late Phase CTMS, and Bioanalytical LIMS into a single, intelligent ecosystem. Built for pharmaceutical, biotechnology, CRO, and research organizations, the platform supports the complete clinical development lifecycle—from protocol planning, volunteer and patient management, site operations, and subject scheduling to sample lifecycle management, bioanalytical testing, data review, and regulatory submissions.By connecting clinical and laboratory operations on a centralized platform, organizations gain real-time visibility, standardized workflows, and end-to-end traceability across studies. AI-enabled capabilities deliver intelligent workflow automation, predictive analytics, smart data validation, anomaly detection, and actionable insights that help research teams identify risks early, optimize resource utilization, reduce manual effort, and make faster, data-driven decisions. Automated alerts, configurable dashboards, and role-based workflows improve operational efficiency while ensuring data integrity and study oversight.Designed to support GxP, GLP, GCP, and 21 CFR Part 11 compliance, the platform provides comprehensive audit trails, electronic records and signatures, secure data management, and seamless interoperability with enterprise systems such as EDC, eTMF, ERP, and laboratory instruments. Its scalable, configurable architecture adapts to diverse study designs and organizational needs, enabling sponsors and CROs to streamline clinical operations, shorten study timelines, enhance collaboration, and deliver high-quality, inspection-ready data with confidence.

Enhance the quality of your evidence with superior electronic Patient-Reported Outcomes (ePRO) and electronic Clinical Reported Outcomes (eClinRO). These Electronic Clinical Outcome Assessments, known as eCOA, evaluate patients' feelings and functionality during clinical trials effectively. By collecting clinical data in an electronic format, you can ensure that the data from your patients is not only high-quality but also in compliance with regulatory standards. In essence, eCOA eliminates the challenges related to paper diaries, such as issues with readability, transcription mistakes, and discrepancies in data. Furthermore, the FDA advocates for the use of ePRO. This involves patients providing insights into their health through various questionnaires or assessments, which may include evaluations of quality of life or activity levels. Clinician-reported outcomes, on the other hand, involve health assessments made by a clinician, with examples such as physical examinations like PASI. Additionally, performance outcomes gauge a patient's ability to complete specific tasks, such as performing a timed activity, thereby offering a comprehensive view of their health status. Ultimately, the transition to eCOA and its associated methods signifies a move towards more reliable and efficient clinical trial processes.

Clin'form is an adaptable and powerful electronic Clinical Outcome Assessment (eCOA) platform that aims to simplify clinical trials for both patients and research sites, improve data integrity, and speed up processes for research teams. Its versatility allows it to be used across various protocols and demographics, making it suitable for any type of questionnaire—including Patient-Reported Outcomes (PRO), Observer-Reported Outcomes (ObsRO), Clinician-Reported Outcomes (ClinRO), and diaries—while catering to individuals of all ages, from children to the elderly. The platform is designed to handle diverse population sizes, effectively managing studies that involve anywhere from a small group to over 10,000 participants spread across multiple regions worldwide. Clin'form integrates smoothly with other clinical systems to provide an efficient workflow, supporting various data collection methods such as dedicated tablets or smartphones, the patient's personal device, web access on any browser, and in-person interviews. Noteworthy features include an integrated tele-visit option to accommodate unexpected changes and patient engagement tools that promote high levels of compliance. Additionally, Clin'form's user-friendly interface ensures that both researchers and participants can easily navigate the platform, making the clinical trial experience more streamlined and effective.

Science 37 is a pioneering clinical research organization that focuses on decentralized clinical trials through its innovative Metasite model, which eliminates the need for physical proximity, allowing patients to engage in studies from virtually anywhere. This method significantly broadens accessibility, reaching over 90% of individuals who might be excluded from conventional site-based research, and harnesses the recruiting capabilities equivalent to 20 sites in one location, thereby offering patients the flexibility they desire. The Metasite operates on a proprietary platform that not only streamlines study orchestration but also facilitates the workflow for both patients and research staff, all while efficiently capturing study data without manual reentry. By centralizing personnel, processes, and technologies, this approach guarantees built-in protocol compliance, which leads to enhanced compliance rates and the collection of high-quality data. Science 37's dedicated in-house medical teams, telemedicine investigators, and mobile nursing professionals are well-versed in the conduct of remote trials spanning various therapeutic areas, thus ensuring comprehensive outreach. This commitment to innovative trial methodologies positions Science 37 at the forefront of transforming the landscape of clinical research.

Longboat is a cloud-based solution designed to support clinical trials, offering an integrated Guided Compliance toolset that assists users consistently throughout the process. By supplying clinical trial site personnel with essential resources, Longboat enables them to concentrate on patient care. Additionally, it allows participants to access vital study details and receive reminders for upcoming visits. The platform facilitates the streamlined management of any amendments to the clinical trial protocol, ensuring a smooth and controlled rollout. Furthermore, it centralizes the secure sharing of regulated documents among sponsors, CROs, and sites, which significantly enhances the startup process and simplifies traditionally labor-intensive tasks for all research stakeholders. Through a unified support platform, all key participants—including clinical operations teams, monitors, site personnel, and trial participants—can access customized content that addresses their individual requirements. This comprehensive approach ensures that site staff are equipped with the necessary tools and resources to remain engaged and compliant while prioritizing the needs of participants. In doing so, Longboat not only improves operational efficiency but also elevates the overall experience for everyone involved in the clinical trial.

PicnicHealth serves as a bridge between patients and researchers, providing comprehensive and purpose-driven real-world data. By engaging with patients who willingly share their medical information for research purposes, we can create an extensive understanding of patient health that encompasses all their healthcare providers, rather than being limited to a single site or specialist. Our established patient communities and efficient recruitment methods through various direct-to-patient channels make it simple to assemble the right cohort of patients. In just ten minutes, patients can register and give consent, gaining access to their own medical records. If you currently have patients involved in ongoing registries or clinical trials, consider directing them to PicnicHealth for streamlined setup. Our research platform is designed to offer tailored real-world data at the individual patient level, allowing for precise specifications regarding the data elements to be extracted from medical records, such as doctors' notes and narrative text. This innovative, patient-focused approach not only enhances the data we gather but also encourages patients to play an active role in the research process. Ultimately, we believe that empowering patients in this way fosters a deeper understanding of health outcomes and improves the overall quality of research.

Greenlight Guru Clinical is the only electronic data capture (EDC) system built specifically for medical device and diagnostics companies. While most EDC platforms were designed for pharmaceutical trials and later adapted for medtech, Greenlight Guru Clinical starts from device and diagnostic requirements: FDA regulations, EU Medical Device Regulation (MDR), In Vitro Diagnostic Regulation (IVDR), and ISO 14155 for clinical investigations. Designed exclusively for medtech, it combines an easy to use clinical data platform with industry leading customer service, helping teams generate reliable, compliant clinical data with confidence. Get a single, validated platform with everything needed to run a medical device or diagnostics study, including: Electronic Data Collection and eCRF, built with pre validated question types that can be cloned and reused across studies ePRO/eCOA, electronic patient and clinician reported outcomes collected in person or remotely eConsent Randomization (RTSM) PMCF Surveys, purpose built for post market clinical follow up under EU MDR Adverse Events Reporting Leading edge, open API for connecting study data to other clinical or quality systems Greenlight Guru Clinical is used by medical device and diagnostics manufacturers running pre-market clinical investigations and post-market surveillance studies, and by contract research organizations (CROs) that specialize in medtech. Every customer gets a dedicated customer success manager with real medtech experience and a validation package included with every product update. For teams that also use Greenlight Guru's quality management system (QMS), Clinical connects directly into one platform covering quality, product development, and clinical evidence.

HEKMA is a pioneering company utilizing artificial intelligence to enhance the efficiency of clinical trials by optimizing patient recruitment, assessing trial feasibility, and fostering patient engagement. Their comprehensive platform caters to a diverse audience, including contract research organizations (CROs), pharmaceutical sponsors, healthcare facilities, and patients, by integrating electronic health records (EHRs) with AI-driven trial matching, clinical trial management solutions, and tools for engaging patients. The core mission of HEKMA is to minimize delays in enrollment, broaden access to clinical trials—especially for underrepresented communities—and streamline the clinical research process to ensure it is more efficient, transparent, and centered around patient needs. With a blend of healthcare knowledge, artificial intelligence capabilities, and clinical operations expertise, HEKMA adheres to crucial industry regulations such as HIPAA, 21 CFR Part 11, GDPR, and HL7/FHIR, ensuring the highest standards of compliance. By harnessing innovative technology, HEKMA aims to transform the landscape of clinical trials, ultimately contributing to advancements in medical research and patient care.

We are confident that Waveform AI has the potential to significantly enhance the healthcare landscape, and we are developing a platform designed to equip clinicians with essential information and support throughout the entire care continuum. Transforming healthcare truly requires collective effort, and to play our part in advancing the industry, we are publishing peer-reviewed research on AI to illustrate its benefits at every stage of the patient care experience. Our platform aims to assist providers in identifying individuals at high risk for sleep apnea by leveraging data from electronic medical records, waveforms, wearables, and various other sources, facilitating timely referrals for diagnosis. By utilizing this data, we can aid healthcare providers in pinpointing the most critical patients among the vast undiagnosed population, categorizing them based on their risk for adverse outcomes and potential healthcare costs. Additionally, we strive to streamline the diagnostic process for clinicians, enabling them to treat more patients efficiently and effectively by improving the overall quality and speed of sleep apnea diagnoses. In doing so, we hope to foster a healthier future for all patients.

Leapcure stands at the forefront of patient recruitment and engagement, bridging the gap between clinical trial sponsors and suitable participants. By leveraging cutting-edge technology and innovative methodologies, we aim to boost both trial enrollment and patient results. Our platform simplifies the recruitment process, allowing for the rapid and efficient identification of qualified candidates for clinical trials. Committed to enhancing medical research, Leapcure strives to make clinical trials more inclusive and impactful. We collaborate intimately with both sponsors and participants to ensure seamless and fruitful trial experiences, which play a crucial role in the advancement of new therapies and treatments. Through our efforts, we are not only improving access to clinical trials but also fostering a more efficient pathway for medical breakthroughs.

SteadyMD serves as a telehealth infrastructure and clinical care platform that facilitates high-quality virtual healthcare experiences for patients and healthcare entities throughout all 50 U.S. states by offering an on-demand, tech-enabled clinician workforce, along with clinical operations, legal and regulatory assistance, and secure telehealth technology. The platform provides a wide array of care services, such as primary care, urgent care, therapy, chronic and condition-specific management, lab order reviews, prescription approvals, and tailored treatment plans that can be accessed via video calls, phone conversations, or asynchronous messaging, thus allowing for smooth patient engagement without the need for face-to-face appointments. Additionally, SteadyMD offers various tools, including Telehealth APIs, a customizable telehealth platform, and the SteadyMD Digital Clinic, which seamlessly integrate with partners’ systems, assist with intake forms and scheduling, and efficiently direct consults to clinicians licensed in the patient’s state while ensuring compliance with HIPAA regulations for security. The platform’s comprehensive approach not only enhances accessibility to healthcare but also streamlines the overall patient experience, making it a valuable resource in the evolving landscape of telemedicine.

Speeding up the creation of crucial medications and ensuring that patients worldwide can access top-notch cancer treatment and research equally. Our technology is transforming how patients access cutting-edge medicines and participate in clinical trials. FICS is a groundbreaking software solution that facilitates the gathering of regulatory-compliant data throughout patient treatment. By integrating previously isolated and non-interacting applications into a comprehensive, seamless platform, FICS is making clinical trials more efficient, quicker, and of superior quality, ultimately enhancing patient outcomes in significant ways.

AssisTek stands out as a frontrunner in cutting-edge clinical technology solutions tailored for clinical research, providing specialized software that optimizes and improves the process of gathering patient data. With a legacy of over 25 years, the company has successfully facilitated more than 800 clinical research trials spanning 46 therapeutic areas, which include upwards of 500 multinational Phase I–IV clinical trials. Their electronic Clinical Outcome Assessment (eCOA) solutions boast scalability, customization, and efficiency, backed by a reliable cloud-based technology platform. Among their extensive product offerings are the TEK eCOA Tablet, which accommodates any questionnaire utilized in clinical trials, TEK eDiary, enabling the collection of patient-reported outcomes from home, TEK Configurator for comprehensive project development in clinical trials, and TEK Study Portal, which consolidates eClinical tracking, training, and reporting into one convenient location. AssisTek's innovative systems and services have established them as the preferred partner for data collection and analytics, winning the trust of both patients and healthcare professionals alike. As they continue to evolve, AssisTek remains committed to enhancing the efficiency and accuracy of clinical research methodologies.

Choose Curebase for your upcoming study and enjoy enhanced diversity, accelerated enrollment, and improved patient retention. Our innovative methodology enables patients to participate from the comfort of their homes while being supported by community physicians, resulting in quicker, more cost-effective, and inclusive research studies. Curebase's distinct combination of in-house virtual Clinical Research Coordinators (CRCs) and a worldwide network of virtual Principal Investigators (PIs) collaborates seamlessly with local doctors to deliver studies directly to patients, no matter their location. Since many patients reside far from conventional research facilities, our trials effectively bring research into their homes and everyday medical environments, including local physician offices. Curebase's infectious disease trials successfully engage patients through a pioneering model that aligns with their needs, utilizing community healthcare and virtual environments, enabling broader participation in important clinical research. By leveraging technology and local connections, Curebase not only improves accessibility but also enhances the overall research experience for patients and providers alike.

REDCap Cloud serves as a comprehensive data-science platform that empowers organizations to gather, integrate, standardize, analyze, and disseminate clinical and research data that meets real-world and regulatory standards, all within a cohesive, standards-driven system. This platform facilitates the complete lifecycle of randomized clinical trials and real-world evidence research by providing diverse modules tailored for intricate trial design and execution, a centralized clinical data hub that integrates both eCRF and non-eCRF sources, AI/ML capabilities for real-time operational and data insights, and seamless connectivity to eSource and EHR systems. Additionally, it enhances patient engagement through tools like ePRO/eCOA and wearable devices, accommodating both hybrid and decentralized trial models. The analytics features include options for synthetic control arms and digital twins, ensuring adherence to global security compliance standards. Ultimately, REDCap Cloud is designed to mitigate data silos, eliminate vendor fragmentation, facilitate bidirectional data flows, and offer sponsors, CROs, and health systems comprehensive visibility and oversight regarding site performance, study data integrity, and regulatory preparedness. By streamlining these processes, organizations can achieve greater efficiency and effectiveness in their research endeavors.

Jeeva's patent-pending modular system is built on the most powerful cloud platform. One login from any browser-enabled device can be used to remotely screen patients, educate, enroll, send SMS, email and generate evidence including electronic patient-reported outcomes. They are tired of waiting for patient recruitment and retention to happen. It is crucial to provide sufficient evidence of safety and efficacy for investigational new medicines in order to receive regulatory agency approval. Jeeva is a great tool for saving time and money for patients, biopharma sponsors, and long-term follow up studies for gene therapy.

AutoCruitment offers an innovative, web-based platform that directly connects with patients, efficiently recruiting, qualifying, and automatically directing the most suitable candidates to clinical trials. By integrating advanced global recruitment technologies, it streamlines the process of finding, screening, and referring patients without relying on the traditional hurdles of provider consent, access to medical records, or investigator site involvement. Utilizing sophisticated online behavior analysis and geotargeting across over 1,500 digital channels—including search engines, display ads, social media platforms, and mobile partnerships—it effectively reaches and pre-qualifies patients in real time through tailored online screening tools that adhere to specific inclusion and exclusion criteria. Research facilities benefit from a secure and intuitive portal that provides immediate referrals, customizable reporting options, and live-tracking dashboards. Additionally, dedicated teams for project management and site engagement collaboratively work to enhance randomization rates, ensuring a more efficient trial process overall. This comprehensive approach not only improves patient recruitment but also fosters stronger connections between research sites and potential trial participants.

Limbic is an innovative clinical-AI platform specifically designed for behavioral health professionals that improves patient accessibility, speeds up assessments, and aids in therapy with reliable AI-driven tools. It integrates seamlessly into referral systems, offering Limbic Access, an interactive intake and screening agent that carries out evaluations, forecasts diagnoses, assesses risk levels, and produces comprehensive clinical reports for healthcare providers. In addition, Limbic provides Limbic Care, an AI companion for patients that offers structured CBT interventions, conversational check-ins, and ongoing support tailored to the individual's therapeutic plan. Central to this platform is the Limbic Layer, a proprietary clinical engine that operates between users and an extensive language model, ensuring safety, clinical accuracy, adherence to regulations, and uniformity. The platform's efficacy is underscored by its impressive diagnostic precision and is supported by peer-reviewed research and recognized regulatory endorsements, including its classification as a Class IIa medical device. Furthermore, Limbic's commitment to enhancing mental health treatment reflects a broader trend in healthcare towards integrating technology for improved patient outcomes.

Complion's platform was designed for clinical researchers. Our solution ensures compliance at the highest level with the lowest effort and the most efficiency. This allows you to concentrate on what really matters: improving and advancing patient outcomes. Our eReg solution is available to all clinical trial stakeholders, whether you are a Sponsor, Research Site or CRO. Reduce costs, avoid redundancy and increase staff productivity. You can easily archive, view and get signatures from any device. An audit trail is built into the system to ensure accuracy and eliminate patient safety risks and study conduct. Our clients include hospitals, cancer centers, and medical centers as well as multi-specialty clinics and dedicated research sites.

The integration of eCOA and digital technologies is paving the way for the future of clinical research, seamlessly connecting traditional methods with innovative, patient-centered approaches. Choose YPrime's eCOA solutions to not only obtain high-quality patient data but also to enhance the overall user experience for sponsors, investigator sites, and patients alike. By employing a flexible software development strategy, YPrime is able to swiftly tailor and adapt functionalities to meet specific study requirements within an impressive timeframe of 8 to 12 weeks. Our engaging and visual design process allows clients to review the system at various stages of development, ensuring they are informed before the system goes live. Additionally, our pre-validated and customizable authoring environment not only streamlines startup timelines but also accommodates post-production adjustments, such as changes to study protocols, making it an indispensable asset for clinical research. This commitment to agility and responsiveness positions YPrime as a leader in the evolving landscape of clinical trials.

RLDatix is a comprehensive AI-powered platform built to support safer, higher-quality healthcare delivery. It connects critical functions such as provider management, safety and risk management, compliance, and patient experience into a single ecosystem. AI-powered insights give leaders greater visibility into performance, risk, and readiness. The platform helps organisations stay aligned with evolving regulatory and accreditation requirements. Centralised policy management and audits reduce administrative burden and improve consistency. RLDatix supports proactive risk identification and prevention across care environments. Data-driven insights enable faster, more confident decision-making. The platform is trusted by over 10,000 healthcare organisations globally. Recognised as Best in KLAS, RLDatix reflects a strong commitment to customer success. Together, its capabilities help organisations deliver safer, more reliable care.

Hospitals demand patient signatures on various intricate forms from different departments. Access offers the most comprehensive eSignature platform tailored for healthcare, featuring remote signing options for services like telehealth, pre-registration, and contactless check-in. The Access eSignature platform equips you with efficient technology tools to handle everything from obtaining a patient’s signature on eConsent to capturing physician signatures, implementing data validation, managing workflows, and integrating with other systems. Access stands out as the sole partner needed to fulfill all electronic signature requirements within your healthcare environment. We emphasize the significance of technology, but we also value building strong relationships. By choosing Access, you gain a dedicated point of contact who becomes familiar with you, your team, and the specific needs of your hospital, ensuring personalized support and service. In this way, Access not only enhances operational efficiency but also fosters a collaborative partnership that can adapt to future challenges.

ClinOne serves as a comprehensive platform that enhances connectivity and empowerment for participants, caregivers, and clinical trial sites by providing essential tools for trial awareness, consent management, and fostering participant engagement and retention, all supported by robust data analytics and standardized interoperability. Among its many features, Site Hub acts as a centralized resource for trial sites to access vital information, including criteria for participant inclusion and exclusion, site resources, and a streamlined systems landing page equipped with single sign-on capabilities and community engagement options. The Connect module further enriches the experience with features like Sponsor & Monitor Hub, trial awareness initiatives, a healthcare provider community, site selection processes, and data addressing diversity, equity, and inclusion. Meanwhile, the Inform module focuses on facilitating consent management and education through eConsent with eSignature options, as well as offering data insights, tele-visit functionalities, and avenues for community collaboration. Additionally, the Empower module enhances the overall trial experience with services such as transportation management, monitoring medication adherence, and providing a dedicated portal for care partners and caregivers, ensuring a holistic approach to participant support throughout the clinical trial journey.

Provide your patients with timely access to essential information to enhance their health journey. Users of Twistle experience improved health outcomes and a reduction in readmissions. The platform allows both clinicians and patients to exchange HIPAA-compliant messages, along with images, videos, and emojis, effortlessly. By tracking real-time interactions through surveys and videos, you can keep your patients engaged and informed. This approach also enables healthcare staff to concentrate on individuals who require more assistance. Quickly create and implement surveys to gather and analyze patient feedback, allowing for prompt action on any concerns to enhance overall satisfaction. Twistle fosters collaboration among all parties involved in patient care, achieving significant results for team-based care initiatives such as Enhanced Recovery After Surgery (ERAS) and Perioperative Surgical Home (PSH). Additionally, Twistle seamlessly integrates with electronic health records, registries, and predictive analytics solutions, while also connecting with devices and wearables to tailor patient communication and engagement strategies. By leveraging these resources, healthcare providers can ensure a more personalized experience for their patients.

Our approach to supporting your team begins with our innovative, multi-faceted platform. Clinical StudyPal is a comprehensive, customizable, and patient-focused technology that streamlines your research processes, making them quicker, simpler, and more economical. As a mobile application, it fosters collaboration and enhances engagement between sites and patients, while its web interface allows for effective study management through robust analytics. Additionally, as a notification system, it ensures that both your patients and study team are consistently informed. What benefits can Clinical StudyPal offer your organization? The more pertinent inquiry might be, what limitations does it have? With our cutting-edge technology and commitment to patient-centric solutions, our dedicated team is eager to assist yours in creating a seamless and successful trial experience tailored to your needs. Ultimately, our goal is to empower your research endeavors in every possible way.

Uncover the most cutting-edge methods in the realm of clinical and patient-reported outcomes data. Our comprehensive solution transcends mere data entry, facilitating a genuinely patient-focused research experience. While our eCOA software is deeply rooted in principles of behavioral science, it has also been designed specifically by healthcare professionals to align with the needs of both sites and sponsors. By emphasizing personal identity, motivational intervals, and significant objectives, we stand out from other eCOA solutions. The Datacubed app features a user-friendly interface that allows participants to quickly engage with what truly matters. It has been highlighted that gathering data is now more straightforward than ever, thanks to our adaptable, user-friendly, and interactive application. As the need for flexibility in trial design continues to grow, we provide versatile data collection options that can be executed in person, remotely, or as a hybrid approach, catering to the diverse requirements of traditional, hybrid, and virtual clinical trials. This adaptability ensures that researchers can effectively capture the most relevant data, regardless of the study format.

Protocol First not only connects disparate locations and dismantles barriers in Clinical Research during the pandemic, but its offerings remain valuable during regular times as well. What was once viewed as optional technology has now become essential. Our solutions facilitate ongoing communication, enabling research not just to persist but to thrive and progress at an accelerated pace. Featuring a fully integrated remote monitoring tool equipped with automatic tagging, our system operates seamlessly with any EDC, anytime, and from any location. Protocol First prioritizes the integration of Sites, Sponsors, CROs, and various functional areas to create a cohesive research environment. We provide holistic solutions that tackle the numerous challenges faced in Clinical Research. The foundation of Protocol First is ensuring accuracy and proper placement of your data, which increasingly incorporates AI, NLP, and ML technologies. A critical component of utilizing AI effectively is establishing a robust structure for your data. The suite of software offered by Protocol First guarantees that data flows efficiently from patients to the FDA, maximizing the potential of data science and enhancing the overall research process. As we move forward, our commitment to innovation will continue to evolve, further amplifying our impact in the field.

LexisNexis Health Equity and Inclusion Insights offers an extensive and actionable dataset focused on the social determinants of health (SDoH) at the individual level. This valuable information empowers healthcare organizations to enhance population health, advance clinical research, and pursue initiatives aimed at promoting health equity. By highlighting obstacles to care, the solution aids in refining care delivery and fostering more equitable healthcare choices, alongside developing diverse clinical research programs. It supplies de-identified datasets that can be integrated with other such datasets through LexisNexis Gravitas, a tokenization tool that utilizes a referential data layer for accurately matching de-identified records from various sources. Achieving health equity hinges on the ability to pinpoint health barriers and predictors of adverse health outcomes, allowing for targeted interventions that can positively impact individual patients. Ultimately, this focus on precision and actionable insights can lead to improved health outcomes across entire communities.

The Patient Pathway App serves as a comprehensive solution for healthcare organizations, enhancing the patient journey, care pathways, and overall patient experience. Designed to deliver vital information directly to patients, the app improves brand reputation and enables individuals to monitor their progress at a lower cost. It features a robust management console, an adaptable timeline, and options for custom branding, allowing healthcare providers to tailor the experience. The platform also focuses on educating and engaging patients, building their confidence, and promoting health initiatives effectively. By raising awareness of crucial health topics such as drug addiction and diabetes management, the app encourages proactive lifestyle choices. Additionally, it offers tools that empower patients to provide feedback through surveys and inquiries, ensuring continuous service improvement. With instant access to essential information, patient demands can be significantly reduced, ultimately facilitating a higher quality of care and improved service delivery. This innovative approach not only enhances patient satisfaction but also supports healthcare providers in fostering healthier communities.

DrCare247 delivers a cloud-based, white-label telemedicine platform that empowers healthcare providers to build and scale branded virtual care experiences. The platform supports a wide range of digital health services, including telehealth consultations, remote patient monitoring, patient scheduling, and secure digital health records. Its modular architecture allows organizations to customize workflows, features, and branding without long development timelines. Providers benefit from secure patient portals that centralize communication, appointments, and medical information in one place. DrCare247 is built to meet strict healthcare compliance standards, including HIPAA, ensuring data protection and privacy. The platform also supports both synchronous and asynchronous care models to improve accessibility and engagement. Integrated physician networks enable timely consultations and prescription services across the U.S. Advanced reporting and operational tools help organizations track performance and patient outcomes. eCommerce and marketing integrations allow healthcare businesses to monetize services efficiently. DrCare247 positions itself as a scalable partner for organizations navigating digital health transformation.

Deep 6 AI revolutionizes the patient enrollment process for clinical trials by changing how researchers pinpoint suitable candidates. By leveraging artificial intelligence and natural language processing, DEEP 6 AI efficiently sifts through both structured and unstructured patient information, enabling the identification of a larger pool of well-matched trial participants in mere minutes instead of the months typically required. The platform collaborates with leading health systems, pharmaceutical companies, and contract research organizations, positioning itself as an essential component of the clinical research ecosystem and significantly hastening the process for patients to access trials. In addition to expediting enrollment, Deep 6 AI’s innovative software evaluates structured data, like ICD-10 codes, alongside unstructured clinical information such as physician notes, pathology reports, and surgical documents that are often difficult to search through. This comprehensive analysis ensures that researchers can quickly find candidates who meet specific criteria, ultimately leading to faster delivery of groundbreaking treatments to those in need.